IR-Center Handelsblatt
Unternehmenssuche:

Nordea Bank Abp

News Detail

EQS-News News vom 26.05.2021

Nordea Bank Abp: Flagging notification

EQS Group-News: Nordea Bank Abp / Key word(s): Miscellaneous
26.05.2021 / 11:40

Nordea Bank Abp: Flagging notification in accordance with Chapter 9, Section 10 of the Securities Markets Act


Nordea Bank Abp
Stock exchange release - Major shareholder announcements
26 May 2021 at 11.15 EET

Nordea Bank Abp has on 26 May 2021 received a notification under Chapter 9, Section 5 of the Securities Markets Act, according to which Sampo plc's shareholding of Nordea Bank Abp's shares and voting rights has decreased below the threshold of 15 per cent on 25 May 2021.

The total number of shares and voting rights in Nordea Bank Abp is 4,049,951,919.

Total positions of Sampo plc according to the notification:

  % of shares and voting rights
(total of A)
% of shares and voting rights through financial instruments
(total of B)
Total of both in % (A + B)
Resulting situation on the date on which threshold was crossed or reached 11.87%   11.87%
Position of previous notification (if applicable) 19.87%   19.87%
 


Notified details of the resulting situation on the date on which the threshold was crossed or reached:

A: Shares and voting rights

Class/type of
shares
ISIN code (if possible)
Number of shares and voting rights % of shares and voting rights
Direct
(SMA 9:5)
Indirect
(SMA 9:6 and 9:7)
Direct
(SMA 9:5)
Indirect
(SMA 9:6 and 9:7)
FI4000297767 480,924,782   11.87%  
SUBTOTAL A 480,924,782   11.87%  
 



For further information:
Matti Ahokas, Head of Investor Relations, +358 9 5300 8011
Group Communication, +358 10 416 8023 or press@nordea.com


The information provided in this stock exchange release was submitted for publication, through the agency of the contact persons set out above, at 11.15 EET on 26 May 2021.
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.



End of Media Release



show this